[
    {
        "text": "This episode was recorded on January 26th\n2021.",
        "start": 0.12,
        "duration": 2.779
    },
    {
        "text": "If we have newer episodes about variants of\nthe COVID-19 virus or the pandemic in general,",
        "start": 2.899,
        "duration": 5.551
    },
    {
        "text": "you’ll find them in the playlist linked\nin the description.",
        "start": 8.45,
        "duration": 2.327
    },
    {
        "text": "♪♪♪",
        "start": 10.777,
        "duration": 2.503
    },
    {
        "text": "A couple weeks ago, we told you about two\nnewer,",
        "start": 13.28,
        "duration": 4.08
    },
    {
        "text": "faster-spreading variants of the COVID-19\nvirus.",
        "start": 17.36,
        "duration": 2.43
    },
    {
        "text": "Well, scientists have been hard at work,",
        "start": 19.79,
        "duration": 1.55
    },
    {
        "text": "and we now know a bit more about them.",
        "start": 21.34,
        "duration": 1.73
    },
    {
        "text": "The news isn’t good.",
        "start": 23.07,
        "duration": 2.01
    },
    {
        "text": "But behind the scary headlines are some caveats\nand clarifications",
        "start": 25.08,
        "duration": 3.41
    },
    {
        "text": "that help shed light on what we actually know.",
        "start": 28.49,
        "duration": 2.55
    },
    {
        "text": "First up: On January 22, the U.K. government’s",
        "start": 31.04,
        "duration": 2.92
    },
    {
        "text": "New and Emerging Respiratory Virus Threats\nAdvisory Group, or NERVTAG, for short,",
        "start": 33.96,
        "duration": 4.969
    },
    {
        "text": "released a preliminary report suggesting one\nof the new variants is more deadly.",
        "start": 38.929,
        "duration": 4.13
    },
    {
        "text": "The report examined multiple independent analyses\nof COVID-19 cases and deaths",
        "start": 43.059,
        "duration": 4.75
    },
    {
        "text": "from research universities in the UK as well\nas Public Health England.",
        "start": 47.809,
        "duration": 4.34
    },
    {
        "text": "All were looking at the B.1.1.7 variant, or\nwhat some have called “the U.K. variant.”",
        "start": 52.149,
        "duration": 5.07
    },
    {
        "text": "It was first detected in the U.K. last September,",
        "start": 57.219,
        "duration": 2.561
    },
    {
        "text": "but has since spread to at least 60 countries\nand 24 U.S. states.",
        "start": 59.78,
        "duration": 4.029
    },
    {
        "text": "Models also suggest it will become the dominant\nvariant in the U.S. by this March,",
        "start": 63.809,
        "duration": 5.011
    },
    {
        "text": "thanks to its increased transmissibility.",
        "start": 68.82,
        "duration": 1.32
    },
    {
        "text": "Now, at first glance, B.1.1.7 didn’t seem\nto be making people sicker.",
        "start": 70.14,
        "duration": 4.35
    },
    {
        "text": "But these new analyses independently looked\nat",
        "start": 74.49,
        "duration": 2.32
    },
    {
        "text": "COVID-19 cases from November 2020 to early\nJanuary 2021.",
        "start": 76.81,
        "duration": 4.69
    },
    {
        "text": "And all of them found that people who had\nB.1.1.7 were more likely to die,",
        "start": 81.5,
        "duration": 4.31
    },
    {
        "text": "about 35% more likely, no matter what age\nthey were.",
        "start": 85.81,
        "duration": 3.93
    },
    {
        "text": "So NERVTAG concluded that there is quote,\n“a realistic possibility,”",
        "start": 89.74,
        "duration": 3.73
    },
    {
        "text": "that this variant is associated with an increased\nrisk of death.",
        "start": 93.47,
        "duration": 3.01
    },
    {
        "text": "That said, there are some limitations to the\nreport.",
        "start": 96.48,
        "duration": 2.45
    },
    {
        "text": "Perhaps the most glaring is that, altogether,\nthe studies examined only",
        "start": 98.93,
        "duration": 2.88
    },
    {
        "text": "8% of the total COVID-related deaths that\noccurred during that time period.",
        "start": 101.81,
        "duration": 4.6
    },
    {
        "text": "That’s a small sample, so it may not be\nrepresentative of the greater UK population,",
        "start": 106.41,
        "duration": 4.82
    },
    {
        "text": "let alone the world.",
        "start": 111.23,
        "duration": 1.0
    },
    {
        "text": "Also, the delay that occurs between when a\nperson’s infected, when they’re tested,",
        "start": 112.23,
        "duration": 3.98
    },
    {
        "text": "and when we know what happens to them makes\nit difficult to analyze data",
        "start": 116.21,
        "duration": 3.52
    },
    {
        "text": "and draw firm conclusions quickly.",
        "start": 119.73,
        "duration": 1.77
    },
    {
        "text": "And the U.K. has seen big spikes in COVID-19\ncases this winter,",
        "start": 121.5,
        "duration": 4.65
    },
    {
        "text": "partly due to the extra-infectious B.1.1.7.",
        "start": 126.15,
        "duration": 2.619
    },
    {
        "text": "So, many experts are emphasizing that we need\nmore research before we can determine",
        "start": 128.769,
        "duration": 4.741
    },
    {
        "text": "whether or not there really is a higher mortality\nrate associated with B.1.1.7.",
        "start": 133.51,
        "duration": 4.16
    },
    {
        "text": "And on the plus side, another preliminary\nreport issued the same week suggested that",
        "start": 137.67,
        "duration": 4.09
    },
    {
        "text": "the BioNTech vaccine does provide protection\nagainst this variant.",
        "start": 141.76,
        "duration": 4.35
    },
    {
        "text": "That is very good news!",
        "start": 146.11,
        "duration": 1.7
    },
    {
        "text": "But… speaking of the vaccines, there’s\na bit of bad news there, too.",
        "start": 147.81,
        "duration": 3.759
    },
    {
        "text": "Two recent preprints suggest that some other\nvariants",
        "start": 151.569,
        "duration": 2.801
    },
    {
        "text": "might make our current vaccines somewhat less\neffective.",
        "start": 154.37,
        "duration": 3.429
    },
    {
        "text": "Now, both of these studies are small and have\nyet to be peer-reviewed.",
        "start": 157.799,
        "duration": 3.041
    },
    {
        "text": "It’s been common during the pandemic to\nrelease",
        "start": 160.84,
        "duration": 2.119
    },
    {
        "text": "preliminary studies to rapidly share information,",
        "start": 162.959,
        "duration": 2.831
    },
    {
        "text": "but it means these papers haven't been through\nan important part of the scientific process,",
        "start": 165.79,
        "duration": 4.22
    },
    {
        "text": "and any findings should be considered cautiously.",
        "start": 170.01,
        "duration": 1.93
    },
    {
        "text": "And the ultimate takeaway is that health experts\nstill say",
        "start": 171.94,
        "duration": 2.9
    },
    {
        "text": "the vaccines will work and are, of course,\nworth getting.",
        "start": 174.84,
        "duration": 2.92
    },
    {
        "text": "What these studies suggest is that mutations\non these variants",
        "start": 177.76,
        "duration": 2.949
    },
    {
        "text": "may present challenges sooner than many scientists\nanticipated.",
        "start": 180.709,
        "duration": 3.331
    },
    {
        "text": "Plus, it’s possible that people who were\ninfected with the earlier versions of the virus",
        "start": 184.04,
        "duration": 4.619
    },
    {
        "text": "can be reinfected with a new variant.",
        "start": 188.659,
        "duration": 1.881
    },
    {
        "text": "The first preprint, uploaded on January 19th,\nlooked at B.1.351,",
        "start": 190.54,
        "duration": 5.039
    },
    {
        "text": "another extra-infectious variant of the virus\nthat was first detected in South Africa.",
        "start": 195.579,
        "duration": 4.69
    },
    {
        "text": "You might have also heard this called “the\nSouth African variant.”",
        "start": 200.269,
        "duration": 2.711
    },
    {
        "text": "Specifically, the researchers wanted to see\nwhether a person’s immune response",
        "start": 202.98,
        "duration": 3.119
    },
    {
        "text": "to COVID-19 would also protect people against\nthis new version of the virus.",
        "start": 206.099,
        "duration": 4.521
    },
    {
        "text": "So, they took blood serum samples from 44\npeople who had been infected",
        "start": 210.62,
        "duration": 3.839
    },
    {
        "text": "with previously circulating variants of SARS-CoV-2.",
        "start": 214.459,
        "duration": 2.691
    },
    {
        "text": "Unfortunately, 21 of those weren’t able\nto stop B.1.351.",
        "start": 217.15,
        "duration": 5.83
    },
    {
        "text": "That suggests people who’ve recovered from\nCOVID-19",
        "start": 222.98,
        "duration": 2.299
    },
    {
        "text": "could still be infected by this variant and\nothers similar to it, like the one emerging from Brazil.",
        "start": 225.279,
        "duration": 5.251
    },
    {
        "text": "The blood samples that did succeed had more\nantibodies in them.",
        "start": 230.53,
        "duration": 3.079
    },
    {
        "text": "This could suggest that people with milder\ninfections are particularly at risk of reinfection,",
        "start": 233.609,
        "duration": 4.24
    },
    {
        "text": "as people tend to produce more antibodies\nafter they’ve been really sick with something.",
        "start": 237.849,
        "duration": 4.18
    },
    {
        "text": "On the upside, when people get two doses of\nthe BioNTech or Moderna vaccines,",
        "start": 242.029,
        "duration": 4.201
    },
    {
        "text": "their bodies produce more neutralizing antibodies\nthan people who’ve been naturally infected.",
        "start": 246.23,
        "duration": 4.149
    },
    {
        "text": "So vaccines might be more protective than\nmild infections.",
        "start": 250.379,
        "duration": 3.86
    },
    {
        "text": "However the second preprint, also uploaded\non January 19,",
        "start": 254.239,
        "duration": 4.28
    },
    {
        "text": "suggests there are also limits there, because\nnot all neutralizing antibodies are the same.",
        "start": 258.519,
        "duration": 4.941
    },
    {
        "text": "For that study, researchers pulled neutralizing\nantibodies from 20 people who’d received",
        "start": 263.46,
        "duration": 4.239
    },
    {
        "text": "both doses of either the Moderna or BioNTech\nvaccines.",
        "start": 267.699,
        "duration": 3.301
    },
    {
        "text": "They then tested how effective their antibodies\nwere against mutations to the virus",
        "start": 271.0,
        "duration": 4.5
    },
    {
        "text": "seen in the variants from South Africa and\nBrazil.",
        "start": 275.5,
        "duration": 2.58
    },
    {
        "text": "And some antibodies were just as effective\nagainst these mutations.",
        "start": 278.08,
        "duration": 3.1
    },
    {
        "text": "But some were only one-third as effective.",
        "start": 281.18,
        "duration": 2.32
    },
    {
        "text": "So, while the vaccines are about 95 percent\neffective against the original SARS-CoV-2,",
        "start": 283.5,
        "duration": 4.78
    },
    {
        "text": "they likely aren’t as robust against the\nnew variants.",
        "start": 288.28,
        "duration": 3.15
    },
    {
        "text": "Even still, experts stress that these vaccines\nare worth getting!",
        "start": 291.43,
        "duration": 3.13
    },
    {
        "text": "Remember, the U.S. F.D.A. said that they'd\nconsider authorizing any vaccine that showed",
        "start": 294.56,
        "duration": 4.47
    },
    {
        "text": "at least a 50% reduction in cases, because\nthat's enough to make a really big difference.",
        "start": 299.03,
        "duration": 4.919
    },
    {
        "text": "And the researchers were clear to note that\nthe vaccines are still expected to provide",
        "start": 303.949,
        "duration": 3.75
    },
    {
        "text": "higher levels of protection than that, especially\nagainst severe sickness.",
        "start": 307.699,
        "duration": 4.141
    },
    {
        "text": "But the data suggest they may not keep people\nfrom having mild or asymptomatic cases.",
        "start": 311.84,
        "duration": 4.44
    },
    {
        "text": "So, while they’ll keep people from dying,\nthey could do less than we’d all like",
        "start": 316.28,
        "duration": 3.9
    },
    {
        "text": "to slow the spread of the virus itself.",
        "start": 320.18,
        "duration": 2.079
    },
    {
        "text": "Luckily, if necessary, the vaccines can be\nupdated",
        "start": 322.259,
        "duration": 2.621
    },
    {
        "text": "to handle new variants in a matter of weeks.",
        "start": 324.88,
        "duration": 2.63
    },
    {
        "text": "In fact, on January 25, Moderna announced\nit’s developing another vaccine",
        "start": 327.51,
        "duration": 3.57
    },
    {
        "text": "that could be used as a booster shot to protect\nagainst the variant from South Africa.",
        "start": 331.08,
        "duration": 4.78
    },
    {
        "text": "Most importantly, health experts say that\nthe faster we vaccinate people",
        "start": 335.86,
        "duration": 3.38
    },
    {
        "text": "while the vaccines are still highly effective,",
        "start": 339.24,
        "duration": 2.419
    },
    {
        "text": "and the better we stick to distancing guidelines\nand other health recommendations,",
        "start": 341.659,
        "duration": 3.901
    },
    {
        "text": "the sooner we can end this pandemic.",
        "start": 345.56,
        "duration": 2.32
    },
    {
        "text": "Thanks for watching this episode of SciShow\nNews!",
        "start": 347.88,
        "duration": 1.71
    },
    {
        "text": "We’re here every Friday with an update on\nwhat’s going on in the world of science.",
        "start": 349.59,
        "duration": 4.41
    },
    {
        "text": "So if you have new or lingering questions\nabout the COVID-19 pandemic,",
        "start": 354.0,
        "duration": 4.039
    },
    {
        "text": "let us know in the comments.",
        "start": 358.039,
        "duration": 1.071
    },
    {
        "text": "We’d love to know what you’re most curious\nor confused about!",
        "start": 359.11,
        "duration": 4.45
    },
    {
        "text": "Every other day of the week,",
        "start": 363.56,
        "duration": 1.0
    },
    {
        "text": "we cover less time-sensitive topics in biology,\nchemistry, physics, and more.",
        "start": 364.56,
        "duration": 4.609
    },
    {
        "text": "So if science is your jam, you might consider\nclicking that subscribe button",
        "start": 369.169,
        "duration": 3.881
    },
    {
        "text": "and even, maybe ringing the notification bell!",
        "start": 373.05,
        "duration": 2.45
    },
    {
        "text": "Is that a thing people do?",
        "start": 375.5,
        "duration": 1.69
    },
    {
        "text": "♪♪♪",
        "start": 377.19,
        "duration": 6.0
    }
]